Results from a phase 1/2 study of 7MW3711: A novel B7-H3 antibody-drug conjugate (ADC) incorporating a topoisomerase I inhibitor in patients with lung cancer.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ziming Li, Qiming Wang, Liang Han, Weiwei Ouyang, XingYa Li, Yu Yao, Longhua Sun, Huaqiu Shi, Shun Lu, Shuhai Wang, Peipei Wang, Kai Chen
Institutions: Shanghai Chest Hospital, Zhengzhou University, Henan Cancer Hospital, Xuzhou Central Hospital, Guiyang Medical University, Guizhou Cancer Hospital, First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Nanchang University, Gannan Medical University, First Affiliated Hospital of Gannan Medical University, Shanghai Jiao Tong University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814407